Join T2EVOLVE at the EHA2023 Congress

by Danny Liu | May 25, 2023 | Uncategorized

T2EVOLVE will be present at EHA2023, the annual congress of the European Hematology Association. The hybrid congress runs from June 8 to June 15 with in-person sessions taking place in Frankfurt am Main in Germany.  T2EVOLVE Project Coordinator Michael Hudecek will be...

Thank you for joining us at the DG-GT workshop in Langen

by Danny Liu | May 3, 2023 | Uncategorized

T2EVOLVE thanks everyone for joining us at our roundtable discussion at the Deutsche Gesellschaft für Gentherapie e.V. (DG-GT) workshop, in Langen, Germany last week. The sessions discussing how we progress the parent-child IND concept from a regulatory point of view...

T2EVOLVE Roundtable Discussion at DG-GT on April 27

by Sebastian | Apr 17, 2023 | Uncategorized

 T2EVOLVE will host a roundtable discussion at the upcoming Deutsche Gesellschaft für Gentherapie e.V. (DG-GT) workshop, in Langen, Germany on April 27-28. Together with moderators Inga Schapitz and Delphine Ammar, panelists from the industry, regulatory bodies, and...

Details about upcoming launch of the European Patient Survey on CAR T-cell therapy

by Danny Liu | Jan 12, 2023 | Uncategorized

Next week, the T2EVOLVE and QUALITOP consortia will launch a survey developed to understand, analyze and meet the needs of European patients treated with CAR-T therapy for hematological cancers. To reach and engage as many patients as possible, T2EVOLVE’s Work...

Happy holidays from everyone at T2EVOLVE

by Danny Liu | Dec 20, 2022 | Uncategorized

Join T2EVOLVE at the 5th European CAR T-cell meeting

by Danny Liu | Nov 22, 2022 | Uncategorized

The 5th European CAR T-cell Meeting takes place in Rotterdam, the Netherlands, on February 9-11, 2023. The meeting is the largest CAR-T event in Europe in 2023. The previous edition of the meeting had more than 1.000 on-site participants and 120 abstracts. For the...